Latest Governance News

QBE Insurance Group has reported its strongest financial performance in over a decade for 2025, with a 7% premium growth and a combined operating ratio improvement to 91.9%. The insurer also raised its dividend and announced a substantial share buyback, signaling confidence in sustained growth.

PWR Holdings Limited has reported a robust half-year performance with revenues climbing 27.8% and net profit rising 38.6%, underpinned by strategic expansion in motorsports and aerospace sectors. The company also announced a higher fully franked interim dividend of 3 cents per share.

NGE Capital Limited reported a remarkable 148% increase in profit after tax for the year ended 31 December 2025, driven by strong gains in uranium and mining investments. The company’s net tangible asset backing per share rose 25.7%, reflecting robust portfolio performance amid a volatile macroeconomic backdrop.

Rio Tinto reported solid 2025 results with an 8% increase in copper equivalent production and disciplined cost management, driving a 9% rise in underlying EBITDA to $25.4 billion. The company marked major project completions and maintained a strong dividend payout.

Wrkr Ltd reports a 43% revenue increase to nearly $7 million in H1 FY2026 but also a 75% rise in net loss, while completing a $15 million capital raise and acquiring payroll compliance firm PaidRight.

Talga Group’s application for a major Swedish government grant was declined due to budget constraints, yet the company remains on track with alternative financing to scale its graphite anode production.

F.F.I. Holdings Limited reported a 12% rise in revenue to $33.9 million for the half year ended December 2025, while net profit after tax fell 12.3% to $1.6 million, impacted by one-off costs and a new government lease. The company declared a fully franked interim dividend of 10 cents per share.

Terragen Holdings reports a 23% reduction in half-year net loss amid strategic shifts and completes a $7 million equity raise to accelerate global commercialisation of its biological agricultural products.

Arovella Therapeutics reported a 22% increase in half-year losses to $1.88 million while securing FDA acceptance of its IND application for lead asset ALA-101, paving the way for first-in-human trials.

3D Energi Limited has offered 41.7 million free attaching options to investors from its October 2025 Placement, aiming to clear trading restrictions despite ongoing ASX suspension and financial challenges.

Cyclopharm Limited is rapidly scaling its US presence for Technegas®, securing new contracts across federal institutions and major health networks in four key regions. The company aims for up to 300 installations by late 2026, boosting recurring revenue streams.

American West Metals Limited reveals a promising Preliminary Economic Analysis for its Storm Copper Project in Canada alongside significant resource growth at its West Desert Project in Utah, positioning itself as a key player in North America's critical metals sector.